Table 2.
Multiplexed electrochemical immunosensors using barcode configurations.
| Electrode | Label | Analyte | Immunoassay | Technique | Linear Range | LOD | Sample | Ref. |
|---|---|---|---|---|---|---|---|---|
| Cancer biomarkers | ||||||||
| G/Au/GCE | THI (or Co or Fc or AQ)-Strept-Biotin-dsDNA/Strept-Biotin-Ab2/AuNPs/SiO2/Fe3O4 | CEA, CA125, PSA, AFP | Sandwich-type; direct detection after conjugation | DPV | 0.2–600 pg·mL−1 CEA; 0.2–1000 pg·mL−1 CA125; 0.2–800 pg·mL−1 PSA; 0.2–800 pg·mL−1 AFP |
48 fg·mL−1 CEA; 77 fg·mL−1 CA125; 60 fg·mL−1 PSA; 62 fg·mL−1AFP |
- | [6] |
| AuNPs/GCE | PVP/GS/PtPdNPs/HRP/AQ PVP/GS/PtPdNPs/HRP/THI | AFP, APT; DCP, AFP-L3, γ-GT, AFU | Sandwich-type; addition of H2O2 | DPV | 0.025–5.0 ng·mL−1 AFP; 0.024–9.6 ng·mL−1 APT; 0.032–3.2 UL−1 DCP; 0.024–2.4 ng·mL−1 AFP-L3; 1.0–9.5UL−1 γ-GT; 1.2–9.0 UL−1 AFU |
0.008 ng·mL−1 AFP; 0.0082 ng·mL−1 APT; 0.01UL−1 DCP; 0.008 ng·mL−1 AFP-L3; 0.33 UL−1 γ-GT; 0.4 UL−1 AFU |
serum | [12] |
| GCE (Hg) | PAMAM-CdS (or ZnS, or PbS) | CA125 CA15-3 CA19-9 |
Sandwich-type; direct detection of Cd, Zn and Ag | SWASV | 0.01–50 U·mL−1 | 0.005 U·mL−1 | serum | [13] |
| IL/rGO/GCE | PtNPs-Cu2+ PtNPs-Cd2+ |
AFP CEA |
Sandwich-type; reduction of metal ions | DPV | 0.05–200 ng·mL−1 | 0.05 ng·mL−1 AFP 0.002 ng·mL−1 CEA |
serum | [14] |
| AuNPs/Chit/GCE | CGS-PB; CGS-TB |
CEA; AFP | Sandwich-type; direct detection | DPV | 0.5–60 ng·mL−1 | 0.1 ng·mL−1 (CEA) 0.05 ng·mL−1 (AFP) |
serum | [33] |
| AuNPs/Chit/GCE | Chit/AuNPs/PB; Chit/AuNPs/Fc |
CEA; AFP | Sandwich-type; direct detection | DPV | 0.05–100 ng·mL−1 | 0.02 ng·mL−1 (CEA) 0.03 ng·mL−1 (AFP) |
serum | [34] |
| HAG/PANI/rGO/GCE | AuNPs/rGO/PB; AuNPs/rGO/PDDA/THI | CEA; AFP | Sandwich-type; direct detection | DPV | 0.6–80 ng·mL−1 | 0.12 ng·mL−1 (CEA) 0.08 ng·mL−1 (AFP) |
serum | [35] |
| AuNPs/GCE | Fc/HRP THI/HRP |
CEA AFP |
Direct assay after addition of H2O2 | DPV | 0.01–50 ng·mL−1 | 0.01 ng·mL−1 | serum | [36] |
| AuNPs/G/GCE | THI-HRP-NPG-MnO2 Fc-HRP-NPG-MnO2 |
CA-15-3 CA-125 |
Sandwich-type; addition of H2O2 | SWV | 0.01–50 U·mL−1 | 3.5 mU·mL−1 (CA-153) 4.1 mU·mL−1(CA-125) |
serum | [37] |
| PDPMT-Cl-Chit/GCE | THI-Fe3O4NPs Fca-Fe3O4NPs |
SCC-Ag CEA |
Sandwich; direct detection | DPV | 0.01–10 ng·mL−1 | 4 pg·mL−1 (SCC-Ag) 5 pg·mL−1 (CEA) |
serum | [38] |
| CD/G/GCE | CD/Fc/G CD/THI/G |
CEA AFP |
Sandwich-type with HRP-Ab2 and H2O2 detection | DPV | 0.003–40 ng·mL−1 CEA 0.001–60 ng mL−1 AFP |
0.8 pg·mL−1 CEA 0.5 pg·mL−1 AFP |
serum | [39] |
| rGO/THI (or PB)/AuNPs/ITO | - | CEA AFP |
Direct detection of of THI or PB | SWV | 0.01–300 ng·mL−1 | 0.650 pg·mL−1 CEA 0.885 pg·mL−1 AFP |
serum | [40] |
| TB (orPB)/AuNPs/TCCRMSs/FTO | - | CEA NSE |
Direct; detection of TB or PB | SWV | 2–25 ng·mL−1 | 0.11 ng·mL−1 CEA 0.08 ng·mL−1 NSE |
serum | [41] |
| HOOC-MBs/SPCE | ACTP/AuNPs ATLP/AuNPs |
p5315, p53392 | Sandwich-type; detection of metals |
SWV | 1–20 ng·mL−1 (p5315) 0.5–20 ng·mL−1 (p53392) |
0.5 ng·mL−1 (p5315) 0.2 ng·mL−1 (p53392) |
serum | [42] |
| GCE (Bi) | G/AuNPs-r-Apo-Cd G/AuNPs-r-Apo-Pb |
AFP CEA |
Sandwich-type; detection of metals | SWASV | 0.001–5 ng·mL−1 | 0.3 pg·mL−1 AFP; 0.35 pg·mL−1 CEA |
serum | [43] |
| rGO | CdSeTe@CdS Ag NCs |
Bcl-2 Bax |
Sandwich-type; direct detection of Cd and Ag | SWASV | 1–250 ng·mL−1 | 0.5 fmol | leukemiaK562 cells | [44] |
| Chit/MWCNTs/GCE | OMC-Zn OMC-Cd |
AFP HER-2 |
Sandwich-type; oxidation of metal ions | DPV | 0.001–150 ng·mL−1 | 0.6 pg·mL−1 AFP 0.35 pg·mL−1 HER-2 |
serum | [45] |
| GCE | EnvisionTM-CdS (or PbS or AuNPs) | AFP CEA CA19-9 |
Sandwich-type; detection of metals | DPASV DPCSV |
0.001–50 ng·mL−1 AFP; CEA; 0.005–100 ng·mL−1 CA19-9 |
0.02 pg·mL−1 AFP; 0.05 pg·mL−1 CEA; 0.3 pg·mL−1 CA19-9 |
serum | [46] |
| Glu/Chit/AuNPs/AuE | BSA/AuNPs-Pb2+ BSA/AuNPs-Cd2+ |
CEA AFP |
Sandwich-type; reduction of metal ions | DPV | 0.01–50 ng·mL−1 | 4.6 pg·mL−1 CEA 3.0 pg·mL−1 AFP |
serum | [47] |
| AuNPs/AuE | AuNPs@MWCNTs-Pb2+ AuNPs@MWCNTs-Cd2+ |
CEA AFP |
Sandwich-type; reduction of metal ions | SWV | 0.01–60 ng·mL−1 | 3.0 pg·mL−1 CEA 4.5 pg·mL−1 AFP |
serum | [48] |
| AuNPs/rGO/Chit | AgNPs/THI/CNSs AgNPs/CNSs |
CEA AFP |
Sandwich-type; direct detection | DPV | 0.01–80 ng·mL−1 | 2.8 pg·mL−1 CEA 3.5 pg·mL−1 AFP |
serum | [49] |
| IL/rGO/PSS/GCE | CGN-THI CGN-DAP CGN-Cd2+ | CEA PSA AFP |
Sandwich-type; direct detection | SWV | 0.01–100 ng·mL−1 | 2.7 pg·mL−1 CEA 4.8 pg·mL−1 PSA 3.1 pg·mL−1 AFP |
serum | [50] |
| AuNPs/AuE | TiO2/Nf- Co(dcbpy)32+ TiO2/Nf- MB |
CA15-3 CA19-9 |
Sandwich-type; direct detection | DPV | 5–100 U·mL−1 CA15-3 1–100 U·mL−1 CA19-9 |
0.3 UmL−1 CA15-3 1.6 UmL−1 CA19-9 |
serum | [51] |
| AuNPs/PAPT/GCE | poly(VFc-ATP) AuNPsPOPD/AuNPs |
AFP CEA |
Sandwich-type; direct detection | DPV | 0.01–100 ng·mL−1 | 0.003 ng·mL−1 AFP 0.006 ng·mL−1 CEA |
serum | [52] |
| AuNPs/G/GCE | PS-Cd2+ PS-Fc |
IL-6 IL-17 |
Sandwich-type; direct detection | SWV | 1–1000 pg·mL−1 IL-6 2–1000 pg·mL−1 IL-17 |
0.5 pg·mL−1 1 pg |
serum | [53] |
| Protein A/Nafion/GCE | GS/AuNPs-THI (or Cobpy)33+ or Fc) |
AFP CEA SS2 |
Sandwich.type; direct detection |
DPV | 0.016–50 ng·mL−1 AFP 0.010–50 ng·mL−1CEA 0.012–50 ng·mL−1 AFP |
5.4 pg·mL−1 AFP 2.8 pg·mL−1 CEA 4.2 pg·mL−1 AFP |
- | [54] |
| AuNPs/PEI/PTCA/GCE | Au@PBNPs/O-GS-Strept-AP; Au@NiNPs/O-GS-Strept-AP | fPSA PSA |
Sandwich-type; AA-P addition | DPV | 0.02–10 ng·mL−1 fPSA 0.01–50 ng·mL−1 PSA |
6.7 pg·mL−1 3.4 pg·mL−1 |
serum | [55] |
| MWCNTs/GCE | AA liposome UA liposome |
NSE ProGRP |
Sandwich-type, direct detection | LSV | 50–1000 pg·mL−1 | 5.0 pg·mL−1 NSE 100 pg·mL−1 ProGRP |
serum | [56] |
| AuNPs/IL/rGO/GCE | Cd (or Pb or Cu) AlgNBs | AFP CEA PSA |
Sandwich-type; direct detection |
DPV | 0.01–100 ng·mL−1 | 0.01 ng·mL−1AFP 0.0086 ng·mL−1CEA 0.0075 ng·mL−1PSA |
serum | [57] |
| GCE (Bi) | PLL/AuNPs/Cd-Apo (or Pb-Apo) | AFP CEA |
Sandwich-type; direct detection |
ASSWV | 0.01–50 ng·mL−1 | 4 pg·mL−1 | serum | [58] |
| Chit/AuNPs/GCE | GA/Chit/pAA NSs-Cu2+ (or Cd2+ or Zn2+) | CEA CA19-9 CA125 CA242 |
Sandwich-type; direct detection |
SWV | 0.1–100 ng·mL−1 CEA 1–150 U·mL−1 CA 19-9, CA125,CA242 |
0.02 ng·mL−1 CEA 0.4 U·mL−1 CA19-9 0.3 U·mL−1 CA125 0.4 U·mL−1 CA242 |
serum | [59] |
Abbreviations: AA, ascorbic acid; AA-P, ascorbic acid 2-phosphate; ACTP, apoferritin templated cadmium phosphates; AFP, alpha fetoprotein; AFP-L3, lens culinaris (LCA)-reactive fraction of AFP; AFU, alpha-L-fucosidase; AgNCs, silver nanoclusters; Alg, alginate; Apo, apoferritin; APT, abnormal prothrombin; ATLP, apoferritin templated lead phosphates; AU, uric acid; Bax, Bcl-2 associated X protein; Bcl, B-cell lymphoma; CEA, Chit, chitosan; CGN, carbon-gold nanocomposite; CGS, carboxyl graphene nanosheet; CNS, carbon nanospheres; DCP, des-c-carboxy prothrombin; Fc. ferrocene; fPSA, free-prostate specific antigen; FTO, fluorine-doped tin oxide; G, graphene; γ-GT, γ-glutamyltranspeptidase; GCE, glassy carbon electrode; O-GS, onion-like graphene sheet; HER-2, human epidermal growth factor receptor type-2; HRP, horse-raddish peroxidase; IL, ionic liquid; NPG, nanoporous gold; NSE, neuron-specific enolase; OMC, ordered mesoporous carbon; pAA, polyacrylic acid; PATP, poly(2-aminothiophenol); PB, Prussian blue; PDPMT-Cl, poly(3-(1,1-o-dimethyl-4-piperidine-methylene)thiophene-2,5-diylchloride); PEI, polyethyleneimine; PLL, poly-L-lysine; POPD, poly(o-phenylenediamine); ProGRP, pro-gastrin-releasing peptide; PTCA, 3,4,9,10-perylenetetracarboxylic acid; SS2, streptococcus suis serotype 2; TB, toluidine blue; TCCMRSs, tryptophan and caffeic acid-based resin microspheres; TB, toluidine blue; THI, thionine; UA, uric acid; VFc-ATP, vinyl ferrocene-2-aminothiophenol.